(OXSQ) Oxford Square Capital - Overview
Stock: Debt, Equity, Tech
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 19.37% |
| Yield on Cost 5y | 25.52% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 90.5% |
| Payout Ratio | 42.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.6% |
| Relative Tail Risk | -2.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.72 |
| Alpha | -26.04 |
| Character TTM | |
|---|---|
| Beta | 0.477 |
| Beta Downside | 0.360 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.98% |
| CAGR/Max DD | -0.12 |
Description: OXSQ Oxford Square Capital January 02, 2026
Oxford Square Capital Corp. (NASDAQ: OXSQ) is a closed-end business development company that functions as a non-diversified private-equity and mezzanine investment vehicle. It acts as the investment adviser to its own portfolio and to the broader TICC platform, targeting both public and private issuers across the technology spectrum.
The firm’s mandate centers on senior and subordinated debt, preferred and common equity, and syndicated bank loans, with typical transaction sizes of $5 million-$30 million. It concentrates on technology-related companies-software, internet, IT infrastructure, telecom, semiconductors, medical-device tech, and related services-generally with annual revenues under $200 million and market caps or enterprise values below $300 million. Investments are structured for a 7-year exit horizon.
As of the latest filing (Q4 2024), OXSQ reported a net asset value (NAV) of roughly $1.1 billion and a distribution yield of about 7.2%, reflecting its focus on higher-yielding credit in a low-interest-rate environment; however, rising Fed rates could compress spreads on new debt deals. The U.S. tech-venture capital market’s recent slowdown and tighter credit conditions are key macro drivers that may affect deal flow and valuation discipline. For a deeper quantitative view, you might explore ValueRay’s analytics on OXSQ’s NAV trends and credit exposure.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -2.56m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.98 > 1.0 |
| NWC/Revenue: 476.4% < 20% (prev -989.2m%; Δ 989.2m% < -1%) |
| CFO/TA 0.06 > 3% & CFO 20.3m > Net Income -2.56m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 12.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.4m) vs 12m ago 22.48% < -2% |
| Gross Margin: 17.73% > 18% (prev -0.03%; Δ 1776 % > 0.5%) |
| Asset Turnover: 3.26% > 50% (prev 2.49%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 0.07 > 6 (EBITDA TTM -2.56m / Interest Expense TTM 8.41m) |
Altman Z'' -5.07
| A: 0.15 (Total Current Assets 53.0m - Total Current Liabilities 4.31m) / Total Assets 314.7m |
| B: -1.13 (Retained Earnings -357.2m / Total Assets 314.7m) |
| C: 0.00 (EBIT TTM 587.6k / Avg Total Assets 313.8m) |
| D: -2.29 (Book Value of Equity -356.4m / Total Liabilities 155.8m) |
| Altman-Z'' Score: -5.07 = D |
What is the price of OXSQ shares?
Over the past week, the price has changed by -4.15%, over one month by +2.94%, over three months by +1.82% and over the past year by -18.46%.
Is OXSQ a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OXSQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.8 | -5.4% |
| Analysts Target Price | 1.8 | -5.4% |
| ValueRay Target Price | 2.3 | 22.2% |
OXSQ Fundamental Data Overview February 03, 2026
P/B = 0.9582
Revenue TTM = 10.2m USD
EBIT TTM = 587.6k USD
EBITDA TTM = -2.56m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 151390.92b USD (from shortTermDebt, last quarter)
Debt = 151.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 100.6m USD (from netDebt column, last quarter)
Enterprise Value = 259.9m USD (159.3m + Debt 151.4m - CCE 50.8m)
Interest Coverage Ratio = 0.07 (Ebit TTM 587.6k / Interest Expense TTM 8.41m)
EV/FCF = 12.81x (Enterprise Value 259.9m / FCF TTM 20.3m)
FCF Yield = 7.81% (FCF TTM 20.3m / Enterprise Value 259.9m)
FCF Margin = 198.5% (FCF TTM 20.3m / Revenue TTM 10.2m)
Net Margin = -25.09% (Net Income TTM -2.56m / Revenue TTM 10.2m)
Gross Margin = 17.73% ((Revenue TTM 10.2m - Cost of Revenue TTM 8.41m) / Revenue TTM)
Gross Margin QoQ = -54.57% (prev 73.99%)
Tobins Q-Ratio = 0.83 (Enterprise Value 259.9m / Total Assets 314.7m)
Interest Expense / Debt = 1.69% (Interest Expense 2.56m / Debt 151.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = 464.2k (EBIT 587.6k * (1 - 21.00%))
Current Ratio = 12.29 (Total Current Assets 53.0m / Total Current Liabilities 4.31m)
Debt / Equity = 0.95 (Debt 151.4m / totalStockholderEquity, last quarter 159.0m)
Debt / EBITDA = -39.23 (negative EBITDA) (Net Debt 100.6m / EBITDA -2.56m)
Debt / FCF = 4.96 (Net Debt 100.6m / FCF TTM 20.3m)
Total Stockholder Equity = 156.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.82% (Net Income -2.56m / Total Assets 314.7m)
RoE = -1.64% (Net Income TTM -2.56m / Total Stockholder Equity 156.5m)
RoCE = 0.38% (EBIT 587.6k / Capital Employed (Equity 156.5m + L.T.Debt 0.0))
RoIC = 0.16% (NOPAT 464.2k / Invested Capital 284.7m)
WACC = 4.58% (E(159.3m)/V(310.6m) * Re(7.67%) + D(151.4m)/V(310.6m) * Rd(1.69%) * (1-Tc(0.21)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 15.69%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈22.7m ; Y1≈14.9m ; Y5≈6.81m
Fair Price DCF = 1.42 (EV 216.8m - Net Debt 100.6m = Equity 116.2m / Shares 81.7m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -29.64 | EPS CAGR: -10.76% | SUE: -0.62 | # QB: 0
Revenue Correlation: -22.62 | Revenue CAGR: -38.38% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.28 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-6.7% | Growth Revenue=+2.3%